| Literature DB >> 31848392 |
Adekunle W Adesanya1,2, Michael J Beauchamp3, Mark D Lavine4, Laura C Lavine4, Fang Zhu4,5, Doug B Walsh3,4.
Abstract
Multiple acaricide resistance in Tetranychus urticae continues to threaten crop production globally, justifying the need to adequately study resistance for sustainable pest management. Most studies on acaricide resistance have focused on the acute contact toxicity of acaricides with little or no information on the behavioral responses elicited after acaricide exposure. Furthermore, the impact of physiological resistance on these behavioral responses remains unknown in most pest species, including T. urticae. We tested the effect of acaricide resistance on contact toxicity, irritancy and repellency of mitochondrial electron transport inhibitor of complex I (MET-I) and mite growth inhibitor (MGI) acaricides on multiple T. urticae strains. We also tested whether acaricides with similar physiological target site/mode of action also elicit similar behavioral effects on T. urticae strains. MET-I acaricides (fenazaquin, fenpyroximate, and pyrabiden) and MGIs (clofentezine, hexythiazox and etoxazole) elicited a dose-dependent irritant and repellent effect on T. urticae. Selection of strains for physiological resistance to these acaricides affected the behavioral response of T. urticae, especially in MET-I resistant strains, that showed reduced irritancy and repellency to MET-I acaricides. Behavioral response also affected the oviposition of T. urticae, where strains generally showed preferential oviposition away from the acaricides. The outcome of this study highlights negative consequences of acaricide resistance that can potentially affect T. urticae management.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31848392 PMCID: PMC6917710 DOI: 10.1038/s41598-019-55708-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Active ingredient, formulation and concentration of acaricides used in this study.
| Active | IRAC | Trade | % a.i. and formulation | *labelled rate ppm a.i. |
|---|---|---|---|---|
| Fenpyroximate | MET-I, 21A | Fujimite | 5 SC | 250 |
| Fenazaquin | MET-I, 21A | Magister | 18 SC | 540 |
| Pyrabiden | MET-I, 21A | Nexter | 42 SC | 600 |
| Clofentezine | Mite growth inhibitor (10A) | Apollo | 5 SC | 626 |
| Etoxazole | Mite growth inhibitor 10B | Zeal | 72 WP | 300 |
| Hexythiazox | Mite growth inhibitor 10A | Savey | 50 DF | 460 |
*Based on the highest field recommended dose on the acaricide label.
Figure 1Schematic outline of the experimental set-up.
Figure 2Contact toxicity (mortality) of mitochondrial electron transport inhibitors of complex I (MET-I; A–C) and mite growth inhibitor (MGI; D–F) acaricides on different Tetranychus urticae strains. Bars represent proportion of dead mites at each acaricide dose. Different letters above bars indicate significant differences in mite mortality (P < 0.05) at tested doses within each T. urticae strain.
Figure 3Contact irritancy of mitochondrial complex I electron transport inhibitors (MET-I; A–C) and mite growth inhibitors (MGI; D–F) on different Tetranychus urticae strains. Bars represent proportion of irritated mites at each acaricide dose. Different letters above bars indicate significant differences in mite irritancy (P < 0.05) at tested doses within each T. urticae strain.
Figure 4Spatial repellency of mitochondrial complex I electron transport inhibitors (MET-I; A–C) and mite growth inhibitors (MGI; D–F) on different Tetranychus urticae strains. Bars represent proportion of repelled mites at each acaricide dose. Different letters above bars indicate significant differences in mite repellency (P < 0.05) at tested doses within each T. urticae strain.
Correlation between contact toxicity, irritancy and repellency of mitochondrial electron transport inhibitors (MET-I) on T. urticae strains.
| Acaricide | Toxicity vs Irritancy | Toxicity vs Repellency | Irritancy Vs Repellency | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| r (CI) | r (CI) | r (CI) | |||||||||
| Fenazaquin | SUS | ||||||||||
| FUJI_RS | −0.22 (−0.6 − (−0.27)) | −0.9 | 0.37 | −0.01 (−0.4–0.39) | −0.37 | 0.71 | |||||
| NEXT_RS | −0.02 (−0.48–0.45) | −0.07 | 0.95 | ||||||||
| 0.22 (−0.27–0.62) | 0.91 | 0.37 | |||||||||
| ZEAL_RS | |||||||||||
| Fenpyroximate | SUS | ||||||||||
| −0.28 (−0.66 − (−0.21)) | −1.2 | 0.26 | 0.26 (−0.24–0.65) | 1.1 | 0.3 | ||||||
| NEXT_RS | 0.34 (−0.14–0.70) | 1.5 | 0.15 | 0.12 (−0.37–0.55) | 0.48 | 0.64 | 0.24 (−0.25–0.64) | 0.99 | 0.34 | ||
| MAG_RS | 0.35 (−0.14–0.7) | 1.5 | 0.16 | ||||||||
| ZEAL_RS | |||||||||||
| Pyrabiden | SUS | ||||||||||
| FUJI_RS | 0.42 (−0.05–0.74) | 1.9 | 0.07 | −0.14 (0.57 − (−0.34)) | −0.59 | 0.56 | |||||
| 0.22 (−0.27 − (−0.62)) | 0.9 | 0.38 | −0.34 (−0.7-_−0.14) | −1.5 | 0.17 | ||||||
| MAG_RS | −0.02 (−0.48–0.44) | −0.1 | 0.91 | 0.04 (−0.43–0.50) | 0.19 | 0.85 | |||||
| ZEAL_RS | −0.43 (−0.74 − (−0.04)) | −1.9 | 0.07 | −0.23 (−0.63–0.25) | −0.99 | 0.34 | |||||
*Degree of freedom in all cases is 16, significant correlation in bold. CI is the confidence interval for r (correlation co-efficient).
Correlation between contact toxicity, irritancy and repellency of mite growth inhibitor (MGI) acaricides on T. urticae strains.
| Acaricide | Toxicity vs Irritancy | Toxicity vs Repellency | Irritancy Vs Repellency | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| r (CI) | t* | r (CI) | t* | r (CI) | t* | |||||
| Clofentezine | SUS | |||||||||
| Apollo_RS | −0.02 (−0.49–0.44) | −0.11 | 0.91 | −0.31 (−0.68–0.19) | −1.3 | 0.22 | ||||
| Savey_RS | 0.34 (−0.15–0.7) | 1.5 | 0.16 | 0.43 (−0.04–0.75) | 1.9 | 0.07 | 0.05 (−0.42–0.51) | 0.21 | 0.83 | |
| Zeal_RS | −0.31 (−0.68–0.19) | −1.3 | 0.22 | |||||||
| Next_RS | 0.28 (−0.2–0.66) | 1.2 | 0.25 | 0.28 (−0.22–0.66) | 1.2 | 0.26 | 0.43 (−0.04–0.74) | 1.9 | 0.07 | |
| Etoxazole | SUS | −0.26 (−0.64–0.23) | −1.1 | 0.29 | 0.18 (−0.71 − (−0.13)) | −0.8 | 0.46 | 0.34 (−0.14–0.7) | 1.5 | 0.16 |
| Apollo_RS | 2.1 | −0.44 (−0.76–0.03) | −1.9 | 0.07 | ||||||
| Savey_RS | −0.36 (−0.71–0.13) | −1.5 | 0.14 | |||||||
| Zeal_RS | −0.3 (−0.68–0.18) | −1.3 | 0.2 | 0.13 (−0.36–0.56) | 0.5 | 0.61 | ||||
| Next_RS | −0.34 (−0.64–0.26) | −1.5 | 0.16 | 0.13 (−0.36–0.56) | 0.51 | 0.61 | −0.18 (−0.59–0.31) | −0.74 | 0.47 | |
| Hexythiazox | SUS | −0.37 (−0.71–0.12) | −1.6 | 0.13 | 0.33 (−0.16–0.69) | 1.4 | 0.18 | |||
| Apollo_RS | −0.3 (−0.67–0.18) | −1.3 | 0.22 | 0.39 (−0.1–0.72) | 1.7 | 0.11 | 0.18 (−0.31–0.59) | 0.73 | 0.48 | |
| Savey_RS | −0.30 (−0.68–0.19) | −1.3 | 0.22 | −0.31 (−0.68–0.18) | −1.3 | 0.21 | ||||
| Zeal_RS | ||||||||||
| Next_RS | 0.41 (−0.1–0.74) | 1.8 | 0.09 | 0.36 (−0.13–0.7) | 1.5 | 0.15 | ||||